Searched for
MERUS NV
Genmab to buy Dutch cancer drugmaker Merus for $8 billionDenmark's Genmab has agreed to acquire Dutch biotech Merus NV for $8 billion in cash, adding the head-and-neck cancer drug petosemtamab to ...
- Load More
Genmab to buy Dutch cancer drugmaker Merus for $8 billionUS stocks today: Nasdaq ends lower with tech slip; investors assess softer jobs data
FMCG companies ride the heatwave to make cool gains
Robust overseas show helps TVS emerge top 2-wheeler company in India
Auto companies stick to fast lane in pay hikes, too
Centre weighs SEZ, GCC pilots to boost PM Internship Scheme
In Graphics: What does a 40% rainfall deficit mean?
India-UK trade pact sparks rush of export orders ahead of July 15 rollout
Yotta Data Services in talks with PE funds to raise $1 billion
Tax department steps up scrutiny of charitable trusts over disclosure mismatches
Soccer: Belgian fury fuels unlikely comeback to down unlucky Senegal
Copyright © 2026 Bennett, Coleman & Co. Ltd. All rights reserved. For reprint rights:
Times Syndication Service